1. Leman, R., et al., Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort. Nucleic Acids Res, 2020 Feb 20. 48(3): p. 1600-1601.

2. Engel, C., et al., Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer, 2020 Feb 15. 146(4): p. 999-1009.

3. Patel, V.L., et al., Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. Cancer Res, 2020 Feb 1. 80(3): p. 624-638.

4. Li, H., et al., Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium. Cancer Epidemiol Biomarkers Prev, 2020 Feb. 29(2): p. 368-378.

5. Puesken, M., et al., Ex Vivo Study of Artifacts Caused by Breast Tissue Markers with Different 1.5 Tesla and 3 Tesla MRI Scanners - A Bicentric Study. Acad Radiol, 2020 Jan 30.

6. Escala-Garcia, M., et al., A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nat Commun, 2020 Jan 16. 11(1): p. 312.

7. Mavaddat, N., et al., Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Res, 2020 Jan 16. 22(1): p. 8.

8. Fachal, L., et al., Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nat Genet, 2020 Jan. 52(1): p. 56-73.

9. Bredart, A., et al., The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions. Eur J Cancer Care (Engl), 2020 Jan. 29(1): p. e13173.